The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

Guan Xiuwen; Wang Haijuan; Ma Fei; Qian Haili; Yi Zongbi; Xu Binghe

首页> 外文期刊>Medicine. >The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

【24h】

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

机译：编程细胞死亡1和编程细胞死亡1配体抑制剂的疗效和安全性为先进的黑色素瘤进行临床试验后的临床试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The purpose of this study was to investigate the efficacy and safety of programmed cell death 1 (PD-1) and programmed cell death 1 ligand (PD-L1) inhibitors using a meta-analysis of present trials for advanced melanoma.

机译：本研究的目的是研究程序化细胞死亡1（PD-1）和编程的细胞死亡1配体（PD-L1）抑制剂的疗效和安全性使用本发明的先进黑色素瘤的荟萃分析。

著录项

来源
《Medicine.》 |2016年第11期|共9页
作者
Guan Xiuwen; Wang Haijuan; Ma Fei; Qian Haili; Yi Zongbi; Xu Binghe;
展开▼
作者单位

Chinese Acad Med Sci Canc Hosp Dept Med Oncol 17 Panjiayuan Nanli Beijing 100021 Peoples R;

Chinese Acad Med Sci Canc Hosp State Key Lab Mol Oncol 17 Panjiayuan Nanli Beijing 100021;

Chinese Acad Med Sci Canc Hosp Dept Med Oncol 17 Panjiayuan Nanli Beijing 100021 Peoples R;

Chinese Acad Med Sci Canc Hosp State Key Lab Mol Oncol 17 Panjiayuan Nanli Beijing 100021;

Chinese Acad Med Sci Canc Hosp Dept Med Oncol 17 Panjiayuan Nanli Beijing 100021 Peoples R;

Chinese Acad Med Sci Canc Hosp Dept Med Oncol 17 Panjiayuan Nanli Beijing 100021 Peoples R;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines [J] . Guan Xiuwen, Wang Haijuan, Ma Fei, Medicine. . 2016,第11期

机译：程序性细胞死亡1和程序性细胞死亡1配体抑制剂对晚期黑色素瘤的疗效和安全性遵循PRISMA指南进行临床试验的荟萃分析
2. Efficacy and safety of programmed cell death-1/programmed cell death ligand-1 inhibitors in advanced urothelial malignancy: A systematic review and meta-analysis [J] . Smita Pattanaik, Sumit Dey, Nishant Jaiswal, Indian Journal of Urology: IJU: Journal of the Urological Society of India . 2019,第2期

机译：程序性细胞死亡-1 /程序性细胞死亡配体-1抑制剂在晚期尿路上皮恶性肿瘤中的疗效和安全性：系统评价和荟萃分析
3. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis [J] . Xiaoying Sun, Raheleh Roudi, Ting Dai, BMC Cancer . 2019,第1期

机译：免疫相关的不良事件与编程的细胞死亡蛋白-1和编程的细胞死亡配体1用于非小细胞肺癌的抑制剂：PRISMA系统审查和META分析
4. The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells [C] . Guan-Huan Du, Xiao-Peng Qin, Qin Li, Academic Committee conference of Shanghai key lab of stomatology . 2011

机译：口腔扁平苔藓中程序性死亡1配体2的高表达水平及其对人T细胞的共刺激作用
5. Characterization of feline programmed cell death 1 and programmed cell death ligand 1 [D] . Folkl, Alex 2008

机译：猫的程序性细胞死亡1和程序性细胞死亡配体1的表征
6. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma [O] . Xiuwen Guan, Haijuan Wang, Fei Ma, -1

机译：程序性细胞死亡1和程序性细胞死亡1配体抑制剂对晚期黑素瘤的功效和安全性
7. The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma [O] . Xiuwen Guan, Haijuan Wang, Fei Ma, 2016

机译：编程细胞死亡1和编程细胞死亡1配体抑制剂的先进黑素瘤的疗效和安全性

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma A Meta-Analysis of Clinical Trials Following the PRISMA Guidelines

摘要

著录项

相似文献

相关主题

期刊订阅